We are live on ! Find out more
COYA icon

Coya Therapeutics

56 hedge funds and large institutions have $32M invested in Coya Therapeutics in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

3.38% less ownership

Funds ownership: 37.94% → 34.56% (-3.4%)

3% less funds holding

Funds holding: 58 → 56 (-2)

13% less capital inflows, than outflows

Capital inflows: $5.59M | Capital outflows: $6.45M

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

Holders
56
Holders Change
-2
Holders Change %
-3.45%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
19
Reduced
11
Closed
12
Calls
$292​K
Puts
–
Net Calls
+$292​K
Net Calls Change
+$236​K

COYA Hedge Fund Activity: Q1 2026 in Review

56 of the 8,241 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q1 2026, worth a combined $32M — down 30% from $46M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of COYA and 9 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 19 added.

The largest buyer was Prosight Management, opening a new position worth an estimated $1.97M. The largest seller was AWM Investment Company, exiting entirely with an estimated $4.2M sold.

  • 56 institutional investors held Coya Therapeutics (COYA) as of Q1 2026, down from 58 in Q4 2025.
  • Funds reported $32M of Coya Therapeutics stock for Q1 2026, down 30% quarter-over-quarter.
  • 9 funds opened new Coya Therapeutics positions in Q1 2026 and 12 closed out, a net change of -3 holders.
  • The largest Coya Therapeutics buyer in Q1 2026 was Prosight Management, an estimated $1.97M added.
  • The largest Coya Therapeutics seller in Q1 2026 was AWM Investment Company, an estimated $4.2M sold.

Based on aggregated 13F filings for Q1 2026.